β¨ Health Notices
1 APRIL 2010 NEW ZEALAND GAZETTE, No. 39 1107
as members of the Ethics Committee on Assisted Reproductive Technology for two-year terms of office commencing on the date of this notification; and also reappoint
Associate Professor Huia Tomlins-Jahnke
as a member of the Ethics Committee on Assisted Reproductive Technology for a three-year term of office commencing on the date of this notification; and appoint
Dr Adriana Gunder
as a member of the Ethics Committee on Assisted Reproductive Technology for a three-year term of office commencing on the date of this notification.
Dated at Wellington this 23rd day of March 2010.
HON TONY RYALL, Minister of Health.
go2431
Medicines Act 1981
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Iressa
Active Ingredient: Gefitinib 250mg
Dosage Form: Coated tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca UK Limited, Cheshire, United Kingdom
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 25th day of March 2010.
ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2387
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of a new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Multiparin
Active Ingredient: Heparin sodium 5000IU/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Artex Limited
Manufacturers: CP Pharmaceuticals Limited, Wrexham, United Kingdom
Eczacibasi Ilac, Luleburgaz, Turkey
Dated this 25th day of March 2010.
ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2386
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Crystaderm
Active Ingredient: Hydrogen peroxide 1%w/w
Dosage Form: Topical cream
New Zealand Sponsor: HMA Research Limited
Manufacturer: Bioglan AB, Malmo, Sweden
Product: Letrole
Active Ingredient: Letrozole 2.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Pharmaceuticals ULC Oncology, Ontario, Canada
Next Page →
β¨ LLM interpretation of page content
π₯
Reappointments/appointment to the Ethics Committee on Assisted Reproductive Technology
(continued from previous page)
π₯ Health & Social Welfare23 March 2010
Ethics Committee, Assisted Reproductive Technology, Reappointment
- Huia Tomlins-Jahnke (Associate Professor), Reappointed to Ethics Committee
- Adriana Gunder (Doctor), Appointed to Ethics Committee
- HON TONY RYALL, Minister of Health
π₯ Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare25 March 2010
Medicines Act, Provisional Consent, Iressa, Gefitinib
- ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare25 March 2010
Medicines Act, Consent, Multiparin, Heparin sodium
- ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare25 March 2010
Medicines Act, Consent, Crystaderm, Letrole
- ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
NZ Gazette 2010, No 39